• Knowledge is priceless
    Business Development
    & Licensing
Best practice in deal-making

Business Development & Licensing


Product Licensing

Companies have products that need further development or commercialisation support. A deal brings validation, resources and funding. Companies, large and small are in need of new products. The people responsible for deals are Business Development executives that coordinate the process until closing the deal. We help in identifying products for licensing, identifying corporate partners for licensing deals, strategic planning, preparation of materials for transactions.


Valuation

It is key in every deal to assess the value. This can only be substantiated if the appropriate projections are made, using industry-accepted principles. The sales of a product can be forecasted using assumptions from independent sources, projecting future cashflows. The cashflows are discounted to generate the Net Present Values which can also be risk-adjusted. Sensitivity analysis provides the range of the valuation. We are experts in Commercial Analysis and Financial Valuations.


Deal Structuring

Where Intellectual Property is typically the subject of a corporate deal, structuring a deal is complicated and the parties must agree numerous points including milestone payments, level of royalties, development, commercialisation efforts, territories, sharing IP, deal duration, termination and other provisions. A deal must be a win-win for both parties but it is during the negotiations that the value is created for the shareholders. Transactions and structuring deals are core to our expertise.


Due Diligence

Whether it's for an investment or for a corporat deal, due diligence is an integral part of the process. Due diligence is performed both commercially and technically. The technical due diligence includes patent checks, scientific data, competitive analysis, development plans, manufacturing, and other areas. Commercial due diligence is closely linked with financial and market analysis, sales and profit projections, sensitivity analysis with risk assumptions and valuations.


Alliance Management

Corporate deals take a long time to source, evaluate, negotiate and finalise and many fall through before being signed. Once a deal is put together though, its value to the company becomes often hundreds of millions and may also reach billions over its life time and when the alliance involves both parties working together, a high degree of co-ordination is necessary to avoid issues becoming problems in an alliance. The role of Alliance Management has become necessary.


New market launch

While relatively few large companies are truly global, many companies become successful in the marketing of their products in their home country or on a regional level, but are normally unable to develop their own infrastructure in other markets. We have a large network of links with licensees and distributors around the world which can facilitate geographical expansion and the introduction of novel healthcare products to new markets for companies that need to expand.

Partnerships are the key to success

We use best practice according to the pharmaceutical industry standards.

Importantly, our associates are from the specialized Business Development & Licensing function of the industry, we have our own proprietary research and best-practice “Deal Tools”, long experience with multinational companies, worldwide coverage, international culture and expertise, industry knowledge and thousands of personal contacts at senior level in the industry.

Our other services

Supporting Investors


We assist investors in independent due diligence, valuations, market forecasts, transactions and expert support in entering and exiting investments in the pharma and biotech sector.

Read more

Supporting law firms


We provide support in legal cases where there are disputes relating to Intellectual Property, Licensing Agreements, Commercialisation and other areas..

Read more

Business Development and Licensing Support UK

"Deal-making is our expertise !

We have a long history of transactions, including private equity and public financing, product licensing, research collaborations, M&A and public listings.

We also assist in market expansion by commercialising products in new geographical territories through creating alliances distributors and regional/local licensees.

Pharmaceutical Business Development and Licensing UK

We focus on delivering results

Our team is comprised of industry professionals with lengthy experience in senior positions, augmented by a wide network of contacts in the pharma and biotech industry and the investment community. Our contribution is tailored to your specific needs.


Innovate. Create. Support. Deliver.



We are a science-driven healthcare UK company based in London, with an international network.

Our focus is on novel products with evidence-based natural compound formulas to support people's health.

Our Photo Stream


Contact Us


Address:
DyoDelta Biosciences Ltd
22a St James's Square
London SW1Y 4JH
U.K.
Phone: +44 20 3239 3022
Email: enquiries @ dyodelta . com

[remove spaces between words]